Add Yahoo as a preferred source to see more of our stories on Google. The FDA has introduced a new draft guidance The US Food and Drug Administration (FDA) has debuted new draft guidance that aims to ...
OSUCCC's informatics program automates biosimilar selection, optimizing prior authorization and reducing administrative burdens, increasing biosimilar utilization by 21.9%. The program earned OSUCCC ...
In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s collaboration with global regulators to streamline development, and its work ...
With the European Medicines Agency (EMA) adopting a recommendation report to streamline the clinical procedures for ...
Hosted on MSN
FDA to streamline approvals for generic biological drugs in latest move targeting health costs
The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
A biosimilar drug manufacturer is concentrating on process optimization to increase uptake of its products in lower-income countries. According to Jeffrey Hausfeld, MD, chairman of the board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results